120 related articles for article (PubMed ID: 31661131)
1. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
Sun C; Sun C; Zhou Y; Yang G; Li G; Xiang C; Ding X; Sun J
Mol Med Rep; 2019 Dec; 20(6):5208-5215. PubMed ID: 31661131
[TBL] [Abstract][Full Text] [Related]
2. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
3. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
[TBL] [Abstract][Full Text] [Related]
4. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
[TBL] [Abstract][Full Text] [Related]
5. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
[TBL] [Abstract][Full Text] [Related]
6. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
7. miR‑15a‑5p acts as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Zhang Z; Gui Y; Mao X; Yang S; Lai Y
Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma.
Chen P; Lin C; Quan J; Lai Y; He T; Zhou L; Pan X; Wu X; Wang Y; Ni L; Yang S; Wang T; Lai Y
Mol Med Rep; 2017 Oct; 16(4):5023-5030. PubMed ID: 28765937
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
Zhao L; Quan J; Li Z; Pan X; Wang J; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Chen Y; Lai Y
Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR‑195‑3p as an oncogene in RCC.
Jin L; Li X; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2017 Apr; 15(4):1916-1924. PubMed ID: 28260025
[TBL] [Abstract][Full Text] [Related]
15. Identification of miR‑30b as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953
[TBL] [Abstract][Full Text] [Related]
16. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
Mol Med Rep; 2018 Jun; 17(6):8510-8517. PubMed ID: 29693121
[TBL] [Abstract][Full Text] [Related]
17. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR‑130b as an oncogene in renal cell carcinoma.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
[TBL] [Abstract][Full Text] [Related]
19. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-7 as an oncogene in renal cell carcinoma.
Yu Z; Ni L; Chen D; Zhang Q; Su Z; Wang Y; Yu W; Wu X; Ye J; Yang S; Lai Y; Li X
J Mol Histol; 2013 Dec; 44(6):669-77. PubMed ID: 23793934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
